HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Piribedil

HCID 4850
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
3605-01-4
Standard SMILES
c1cnc(N2CCN(Cc3ccc4c(c3)OCO4)CC2)nc1
InChIKey
OQDPVLVUJFGPGQ-UHFFFAOYSA-N
Molecular formula
C16H18N4O2
Average molar mass
298.34 g/mol
Monoisotopic mass
298.14297583

Overview

2-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]pyrimidine is a N-arylpiperazine.

Names & identifiers

Preferred name
Piribedil
IUPAC
2-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]pyrimidine
English name
2-[4-(1,3-Benzodioxol-5-ylmethyl)piperazin-1-yl]pyrimidine
Molecular formula
C16H18N4O2
Molecular weight
298.34

Names & synonyms

piribedil3605-01-4Trivastal2-(4-Piperonyl-1-piperazinyl)pyrimidine2-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]pyrimidineET-495EU-4200EU 4200ET 495PiribedilumDTXSID9045188DO22K1PRDJ
Show more names
PibedilPiribediPirbedilTrivastanPIRIBEDIOL
DTXCID7025188Pyrimidine, 2-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-PiribendylPyrimidine, 2-(4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl)-2-{4-[(2H-1,3-benzodioxol-5-yl)methyl]piperazin-1-yl}pyrimidine2-(4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl)pyrimidineTrivastal lp2-(4-((2H-1,3-benzodioxol-5-yl)methyl)piperazin-1-yl)pyrimidine

Database identifiers

CAS
3605-01-4
PubChem CID
4850
DTXSID
DTXSID9045188
ChEMBL
CHEMBL1256997、CHEMBL1371770
ChEBI
CHEBI:92833
UNII
DO22K1PRDJ
EC Number
222-764-6
Nikkaji
J8.178G

Properties

Computed structural properties

XLogP
1.8
Topological polar surface area
50.7 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
6
Rotatable bonds
3
Heavy atoms
22
Formal charge
0
Complexity
356

Experimental & physicochemical properties

Drugs · 2 items

Pharmaceuticals

Pharmaceuticals -> Listed in ZINC15

LogP2.84
Collision Cross Section157.69 Ų [M+H-H2O]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physicochemical properties

Melting point
98 ° · 98°
Boiling point
439.76 °C · 439.76°C (rough estimate)
Density
1.1183 · 1.1183 (rough estimate)
refractive index
1.6 · 1.6000 (estimate)
storage temp.
2 · 2-8°C
solubility
Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
pka
7.17 · 7.17±0.10(Predicted)
form
Solid
color
White
Merck

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Warning

H302 (50%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P260, P261, P263, P264, P270, P271, P273, P301+P317, P304+P340, P318, P319, P330, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Hazard Classes and CategoriesAcute Tox. 4 (50%)

Safety data

rtecs
UV9704000
hs_code
2933.59.8000
Toxicity
LD50 in mice (mg/kg): 88 i.v., 690 i.p., 1460 orally (Laubie)
Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H302-H315-H319-H335
Precautionary statements
P261-P305+P351+P338

Chemistry & industry

Pharmacology

ATC Code · 3 items

N04BC08

N - Nervous system

QN - Nervous system

MeSH Pharmacological Classification · 2 items

Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists.

Drugs that bind to and activate dopamine receptors.

Uses & manufacturing

UsesUse (kg; approx.) in Germany (2009): >250
Applications · 1 item

UsesPiribedil is an antiparkisonian agent that acts as a dopamine agonist. Piribedil also displays α2-adrenergic antagonist properties. Piribedil has also been shown to counteract age-related memory impairment by improving memory and attention as well as increasing the velocity of psychomotor reactions and lability of nervous processes.

Upstream & downstream products

Upstream raw materials

2-Chloropyrimidine1-Piperonylpiperazine1-Phenyl-1-propanolPiperonylic acidPiperonyl chloridePiperonyl alcohol2-(1-Piperazinyl)pyrimidine

Related reactions

1 records
New reaction record
HRID 1885712 reaction equation
HRID 1885712As reactant

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
14 · 14,7493
InChI
InChI=1S/C16H18N4O2/c1-4-17-16(18-5-1)20-8-6-19(7-9-20)11-13-2-3-14-15(10-13)22-12-21-14/h1-5,10H,6-9,11-12H2
InChIKey
OQDPVLVUJFGPGQ-UHFFFAOYSA-N
SMILES
C1(N2CCN(CC3=CC=C4OCOC4=C3)CC2)=NC=CC=N1
CAS DataBase Reference
3605 · 3605-01-4(CAS DataBase Reference)
FDA UNII
22 K1PRDJ · DO22K1PRDJ
ATC code
4 BC08 · N04BC08
Comptox DTXSID
9045188 · DTXSID9045188
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H335
Precautionary statements
261 · P261-P305+P351+P338
RTECS
9704000 · UV9704000
HS Code
2933.59 · 2933.59.8000
Toxicity
50 in · LD50 in mice (mg/kg): 88 i.v., 690 i.p., 1460 orally (Laubie)
4-Bromo-1,2-(methylenedioxy)benzene
Pyrimidine, 2-(4-methyl-1-piperazinyl)- (9CI)
Piperonyl aldehyde

Additional notes

DefinitionChEBI: 2-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]pyrimidine is a N-arylpiperazine.